Covestor’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-132
Closed – – 2565
2026
Q2
$0 Buy
132
+93
+238% +$134 ﹤0.01% 2630
2026
Q1
$0 Buy
39
+25
+179% +$47 ﹤0.01% 2469
2025
Q4
$0 Hold
14
– – ﹤0.01% 2449
2025
Q3
$0 Hold
14
– – ﹤0.01% 2471
2025
Q2
$0 Sell
14
-1
-7% -$4 ﹤0.01% 2426
2025
Q1
$0 Hold
15
– – ﹤0.01% 2430
2024
Q4
$0 Buy
15
+1
+7% +$8 ﹤0.01% 2441
2024
Q3
$0 Sell
14
-1
-7% -$7 ﹤0.01% 2424
2024
Q2
$0 Buy
15
+5
+50% +$32 ﹤0.01% 2438
2024
Q1
$0 Buy
10
+4
+67% +$37 ﹤0.01% 2434
2023
Q4
$0 Sell
6
-1
-14% -$8 ﹤0.01% 2354
2023
Q3
$0 Sell
7
-1
-13% -$12 ﹤0.01% 2339
2023
Q2
$0 Hold
8
– – ﹤0.01% 2338
2023
Q1
$0 Hold
8
– – ﹤0.01% 2245
2022
Q4
$0 Sell
8
-1
-11% -$10 ﹤0.01% 2269
2022
Q3
$0 Sell
9
-1
-10% -$13 ﹤0.01% 2236
2022
Q2
$0 Buy
10
+1
+11% +$17 ﹤0.01% 2102
2022
Q1
$0 Sell
9
-2
-18% -$57 ﹤0.01% 2245
2021
Q4
$0 Buy
+11
New +$501 ﹤0.01% 2192

Other funds holding HCAT

Covestor's HCAT Position: Q3 2026 in Review

Covestor sold out of Health Catalyst (HCAT) in Q3 2026, closing a stake of 132 shares.

Covestor first reported a position in HCAT in Q4 2021 and held it in 19 quarters. The position peaked at $0 in Q2 2026. 76 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.

  • Covestor reported no remaining Health Catalyst position as of Q3 2026 after selling out during the quarter.
  • Covestor sold 132 Health Catalyst shares in Q3 2026.
  • Covestor first reported a position in Health Catalyst in Q4 2021 and held it in 19 quarters.
  • Covestor's Health Catalyst position peaked at $0 in Q2 2026.
  • 76 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.